Lipid News

An ever-growing role for a tiny lipid

Nicholas Vitale
By Nicholas Vitale
June 01, 2019

Critical signaling functions have been attributed to phosphatidic acid, or PA, the smallest building block in phospholipid biosynthesis. With a small head group and a net negative charge ranging from -1 to -2 depending on pH, PA can modulate local membrane geometry and recruit a large set of specific proteins to confined membrane subdomains; a recent review by Emeline Tanguy and colleagues summarizes both of these essential actions for PA’s signaling function. PA is versatile and challenging because it can be produced and metabolized by a large set of enzymes.

Although PA is present at low levels in most cell types, it appears to be critical for neuronal and glial cell function. Several neurological diseases maybe attributed, at least in part, to altered PA synthesis and/or catabolism. For example, Ricardos Tabet and colleagues proposed in 2016 that an alteration of the PA/diacylglycerol balance could be a main cause of fragile X syndrome, a genetic cause of intellectual disability. They showed that diacylglycerol kinase-kappa, or DGK-kappa, mRNA was the main target of fragile X mental retardation protein and that reduced DGK-kappa expression impaired PA synthesis in neurons from mice bred not to express FMR1, a protein that male fragile X patients lack. Silencing DGK-kappa in pyramidal neurons from the CA1 region of the hippocampus largely reproduced fragile X symptoms. This PA/DAG imbalance is thus likely to affect DAG and PA downstream signaling required for both maturation of dendritic spines and establishment of correct synaptic plasticity.
 

Phosphatidic acid figure Phosphatidic acid is defined by its shape and charge. This conical lipid generates negative membrane curvature and is negatively charged, thereby recruiting positively charged proteins. Nicolas Vitale

Maria Zeniou–Meyer and colleagues in 2008 proposed that the loss of expression of the kinase RSK2, which leads to Coffin–Lowry syndrome (a rare syndromic form of mental retardation), reduced PA synthesis and distorted neurosecretion. Increased PA synthesis has been reported in gliobastoma, the most frequent and aggressive brain cancer. A link between brain PA levels and Alzheimer’s disease also is starting to emerge, but the exact effects of PA imbalance in neurodegeneration and cognitive deficits has not been identified. Finally, reduced PA synthesis may contribute to fetal alcohol spectrum disorders, as ethanol leads to phospholipase D-mediated phosphatidylethanol production at the expense of PA.

Many cellular pleiotropic functions of PA rely on its ability to regulate actin cytoskeleton dynamics and to modulate membrane-involved functions. The former occurs mainly through PA’s ability to modulate the activity of small GTPases, including Rho and Arf members. The latter probably results both from the original cone shape structure of PA favoring negative membrane curvature and from PA’s net negative charge allowing local recruitment of specific proteins. One remaining challenge is to define precisely sites of PA synthesis within the brain and at the subcellular level in neurons. Recent improvements in lipidomics allow for sensitive quantification of dozens of PA species made with different fatty acids. According to a study by Nawal Kassas and colleagues, the development of novel genetically encoded PA sensors also will be crucial in localizing and potentially quantifying changes in PA and perhaps different PA species.

Despite PA’s low abundance, its relative simplicity, and the complexity of its metabolic and signaling pathways, improved understanding of its multiple functions in brain development and function is now within reach.

Nicholas Vitale
Nicholas Vitale

Nicholas Vitale is a group leader at the Institut des Neurosciences Cellulaires et Intégratives at the Centre National de la Recherche Scientifique & Université de Strasbourg and a member of the Journal of Biological Chemistry’s editorial board. Follow him on Twitter.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

A proposal to use CRISPR to prevent opioid overdoses is a useless approach to healthcare
News

A proposal to use CRISPR to prevent opioid overdoses is a useless approach to healthcare

September 27, 2020

Nicholas McCarty of New York University writes that genetically engineering drug users’ brains is short-sighted, reactive and unnecessary.

Lessons from how the polio vaccine
News

Lessons from how the polio vaccine

September 26, 2020

Despite the polio vaccine’s long-term success, manufacturers, government leaders and the nonprofit that funded the vaccine’s development made several missteps.

From the journals: MCP
Journal News

From the journals: MCP

September 25, 2020

How marine iguanas mark their turf. A new way to study Parkinson’s disease. Glycosylation in influenza A. Read about recent papers on these topics in the journal Molecular & Cellular Proteomics.

Gut microbiome shaped by dietary sphingolipids
Journal News

Gut microbiome shaped by dietary sphingolipids

September 22, 2020

A new tracing method described in the Journal of Lipid Research offers clues on how a macronutrient interacts with the microbes that live inside us.

From the journals: JBC
Journal News

From the journals: JBC

September 21, 2020

Proteases that fire up the flu. A sulfate pocket to take out MRSA. Proteins that prompt cancer protrusions. Read about recent papers on these topics and more.

AeroNabs promise powerful, inhalable protection against COVID-19
News

AeroNabs promise powerful, inhalable protection against COVID-19

September 20, 2020

As the world awaits vaccines to bring the COVID-19 pandemic under control, UC San Francisco scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease.